Market Overview

10 Biggest Price Target Changes For Monday

Share:
  • H.C. Wainwright raised Rewalk Robotics Ltd (NASDAQ: RWLK) price target from $4 to $9. Rewalk Robotics shares closed at $5.21 on Friday.
  • Citi cut the price target on Endo International PLC (NASDAQ: ENDP) from $19 to $5. Endo International shares closed at $4.05 on Friday.
  • BMO Capital cut the price target for Dow Inc. (NYSE: DOW) from $58 to $52. Dow shares closed at $51.15 on Friday.
  • Deutsche Bank boosted the price target for Kimberly Clark Corp (NYSE: KMB) from $113 to $122. Kimberly Clark shares closed at $137.65 on Friday.
  • Baird raised the price target for Titan Machinery Inc. (NASDAQ: TITN) from $18 to $24. Titan Machinery shares closed at $15.90 on Friday.
  • Deutsche Bank boosted the price target for Corteva Inc (NYSE: CTVA) from $30 to $32. Corteva shares closed at $25.19 on Friday.
  • BMO Capital lifted Keurig Dr Pepper Inc (NYSE: KDP) price target from $27 to $34. Keurig Dr Pepper shares closed at $28.63 on Friday.
  • Baird boosted the price target for Deere & Company (NYSE: DE) from $129 to $175. Deere shares closed at $151.51 on Friday.
  • UBS raised the price target for Lululemon Athletica inc. (NASDAQ: LULU) from $182 to $186. Lululemon shares closed at $176.71 on Friday.
  • Deutsche Bank boosted the price target for Casey's General Stores Inc (NASDAQ CASY) from $147 to $166. Casey's shares closed at $151.98 on Friday.

 

 

Posted-In: Price Target ChangesPrice Target Intraday Update Analyst Ratings

 

Related Articles (DE + CTVA)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
ABTMaintains93.0
COSTMaintains300.0
IBMReinstates147.0
NFLXMaintains450.0
ACSTInitiates Coverage On7.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Calithera's Kidney Cancer Drug Doubles Progression-Free Survival Vs. Chemotherapy

Flex Pharma Falls After Salarius Pharma Merger Delay